CAMP4 Therapeutics (CAMP) Reiterated at Overweight by Cantor Fitzgerald After Model Update
Tweet Send to a Friend
Cantor Fitzgerald analyst Steve Seedhouse reiterated an Overweight rating and $7.00 price target on CAMP4 Therapeutics Corp (NASDAQ: CAMP).The analyst ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
